If you can't see this email correctly, click here.
  VISIONS IN VALUATION  
Forecasting Sales - Competition Scenarios

This first article on sales forecasting explains how to estimate the effect of different competition scenarios to estimate peak sales.


  Discount Rates in Pharma and Biotech

While most valuation parameters can be justified referring to market research, publications, or historical data, the models for the discount rate are surprisingly poor. Standard approaches like CAPM yield unsatisfactory results, and adjustments to the calculated discount rate are prone to subjective assumptions. This article explains how you can determine a realistic discount rate that corresponds to the market reality.
 
   
 
  EVENTS  

2008/02/6-8

Workshop on license contract negotiation.
Mont Tremblant, CANADA

2008/03/11

License contract valuation in Excel.
Basel, SWITZERLAND


Professional Valuation Made Easy - ri:val Now Prepares Your Excel Sheets

The leading valuation solution again got better. Avance releases ri:val 2.4. featuring:

With one click you can now export project and license contract valuations into Excel. ri:val constructs the valuation sheet with all formulas and parameters which you can easily change.

The userfriendly input into ri:val makes valuation an easy task for everbody. You don't have to be an expert in setting up spreadsheets anymore to successfully negotiate your deals.

 
THE KEY TO SUCCESS  

The guide to valuation in pharma and biotech. Become an expert yourself.


LINKS  
> www.avance.ch
> www.rival.ch
You can sign up for News in Avance, change your e-mail address, or unsubscribe on our newsletter here.
Copyright: Avance, Basel GmbH - Pfluggässlein 14 - CH - 4001 Basel